Home
Scholarly Works
Anti-thymocyte globulin induction therapy usage is...
Conference

Anti-thymocyte globulin induction therapy usage is not associated with short and long-term survival differences in heart transplant patients

Authors

Jia S; Nagpal D; Goldraich L; Davey RA; Mckelvie R; De S; Smith SJ

Volume

21

Pagination

pp. 280-280

Publisher

WILEY

Publication Date

May 1, 2019

Conference proceedings

EUROPEAN JOURNAL OF HEART FAILURE

ISSN

1388-9842

Labels

Contact the Experts team